Fundz

Caristo Diagnostics Appoints Stephen M. Deitsch as Chief Executive Officer

PRIVATEApr 14, 2026

Position

Chief Operating Officer

Company

Caristo Diagnostics

Frank Cheng
BiotechnologyHealth CareArtificial IntelligenceMedicalHealth Diagnostics

Description

Caristo Diagnostics has announced the appointment of Stephen M. Deitsch as Chief Executive Officer, effective immediately. Deitsch brings over 25 years of experience in medtech and healthcare, succeeding Frank Cheng who is now the Chief Operating Officer.

Quick answer

Caristo Diagnostics Appoints Stephen M. Deitsch as Chief Executive Officer (April 14, 2026).

What did Caristo Diagnostics announce on April 14, 2026?
Caristo Diagnostics has announced the appointment of Stephen M. Deitsch as Chief Executive Officer, effective immediately. Deitsch brings over 25 years of experience in medtech and healthcare, succeeding Frank Cheng who is now the Chief Operating Officer.
What does Caristo Diagnostics do?
Caristo Diagnostics is a global leader in AI technology for cardiovascular disease, founded as a spin-out from the University of Oxford.
Which similar companies made leadership changes around the same time?
Vitals Vault (April 4, 2026), Zimmer (April 28, 2026), RetinalGeniX Technologies (March 26, 2026) and NetraMark (May 4, 2026) also announced leadership changes within 45 days of Caristo Diagnostics.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Health Diagnostics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Caristo Diagnostics, and when

A new leader at Caristo Diagnostics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Caristo Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Caristo Diagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Caristo Diagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Caristo Diagnostics

About

Caristo Diagnostics is a global leader in AI technology for cardiovascular disease, founded as a spin-out from the University of Oxford. Its award-winning technology helps detect hidden heart disease and identify people at risk of heart attack before symptoms appear. Working with physicians, hospitals, research institutions, and pharmaceutical partners, Caristo aims to save lives through early detection and personalized prevention.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Caristo Diagnostics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Michel
Likely contact at this company
••••••••@••••••••

See Michel's verified email →

Matt
Senior decision-maker at this company
••••••••@••••••••

See Matt's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Caristo Diagnostics's next move

Learn about Strategic plan

Caristo Diagnostics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.